SAM
AMED

Silvercrest Asset Management’s Amedisys AMED Stock Holding History

Silvercrest Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-48,347
Closed -$11.4M – 812
2020
Q3 		$11.4M Sell
48,347
-2,181
-4% -$496K 0.1% 211
2020
Q2 		$10M Sell
50,528
-9,293
-16% -$1.73M 0.09% 209
2020
Q1 		$11M Sell
59,821
-30,794
-34% -$5.48M 0.12% 180
2019
Q4 		$15.1M Sell
90,615
-596
-0.7% -$88.6K 0.12% 184
2019
Q3 		$11.9M Buy
+91,211
New +$11.9M 0.1% 203

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Silvercrest Asset Management's AMED Position: Q4 2020 in Review

Silvercrest Asset Management sold out of Amedisys (AMED) in Q4 2020, closing a stake of 48,347 shares — an estimated $11.4M sold.

Silvercrest Asset Management first reported a position in AMED in Q3 2019 and held it in 5 quarters. The position peaked at $15.1M in Q4 2019. 396 funds tracked by Wall St. Rank hold AMED as of Q4 2020.

  • Silvercrest Asset Management reported no remaining Amedisys position as of Q4 2020 after selling out during the quarter.
  • Silvercrest Asset Management sold 48,347 Amedisys shares in Q4 2020, an estimated $11.4M.
  • Silvercrest Asset Management first reported a position in Amedisys in Q3 2019 and held it in 5 quarters.
  • Silvercrest Asset Management's Amedisys position peaked at $15.1M in Q4 2019.
  • 396 funds tracked by Wall St. Rank held Amedisys as of Q4 2020.

Based on Silvercrest Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.